Black Rock Health Sciences Trust BME
We take great care to ensure that the data presented and summarized in this overview for BlackRock Health Sciences Trust is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding BME
View all-
Wells Fargo & Company San Francisco, CA448KShares$18.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY368KShares$15.3 Million0.0% of portfolio
-
Nova R Wealth, Inc.333KShares$13.9 Million7.19% of portfolio
-
1607 Capital Partners, LLC Richmond, VA228KShares$9.48 Million0.83% of portfolio
-
Invesco Ltd. Atlanta, GA201KShares$8.35 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC189KShares$7.86 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN159KShares$6.63 Million0.0% of portfolio
-
Ubs Group Ag142KShares$5.91 Million0.0% of portfolio
-
Cornerstone Advisory, LLC136KShares$5.67 Million0.82% of portfolio
-
Royal Bank Of Canada Toronto, A6133KShares$5.55 Million0.0% of portfolio
Latest Institutional Activity in BME
Top Purchases
Top Sells
About BME
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Insider Transactions at BME
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 31
2024
|
Kyle Mc Clements |
SELL
Sale (or disposition) back to the issuer
|
Direct |
625
-18.6%
|
$25,625
$41.48 P/Share
|
|
Jan 31
2024
|
Kyle Mc Clements |
BUY
Exercise of conversion of derivative security
|
Direct |
625
+15.68%
|
-
|
|
Jan 31
2024
|
H Erin Xie |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,946
-100.0%
|
$612,786
$41.48 P/Share
|
|
Jan 31
2024
|
H Erin Xie |
BUY
Exercise of conversion of derivative security
|
Direct |
14,946
+50.0%
|
-
|
|
Jan 31
2024
|
Christopher Accettella |
SELL
Sale (or disposition) back to the issuer
|
Direct |
202
-20.8%
|
$8,282
$41.48 P/Share
|
|
Jan 31
2024
|
Christopher Accettella |
BUY
Exercise of conversion of derivative security
|
Direct |
202
+17.21%
|
-
|
|
Jan 31
2024
|
Xiang Liu |
SELL
Sale (or disposition) back to the issuer
|
Direct |
188
-100.0%
|
$7,708
$41.48 P/Share
|
|
Jan 31
2024
|
Xiang Liu |
BUY
Exercise of conversion of derivative security
|
Direct |
188
+50.0%
|
-
|
|
Jan 31
2023
|
Xiang Liu |
SELL
Sale (or disposition) back to the issuer
|
Direct |
96
-100.0%
|
$4,128
$43.56 P/Share
|
|
Jan 31
2023
|
Xiang Liu |
BUY
Exercise of conversion of derivative security
|
Direct |
96
+50.0%
|
-
|
|
Jan 31
2023
|
Kyle Mc Clements |
SELL
Sale (or disposition) back to the issuer
|
Direct |
616
-54.18%
|
$26,488
$43.56 P/Share
|
|
Jan 31
2023
|
Kyle Mc Clements |
BUY
Exercise of conversion of derivative security
|
Direct |
616
+35.14%
|
-
|
|
Jan 31
2023
|
H Erin Xie |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,966
-100.0%
|
$600,538
$43.56 P/Share
|
|
Jan 31
2023
|
H Erin Xie |
BUY
Exercise of conversion of derivative security
|
Direct |
13,966
+50.0%
|
-
|
|
Jan 31
2023
|
Christopher Accettella |
SELL
Sale (or disposition) back to the issuer
|
Direct |
206
-22.2%
|
$8,858
$43.56 P/Share
|
|
Jan 31
2023
|
Christopher Accettella |
BUY
Exercise of conversion of derivative security
|
Direct |
206
+18.17%
|
-
|
|
Jan 31
2023
|
Jeffrey Gene Lee |
SELL
Sale (or disposition) back to the issuer
|
Direct |
204
-100.0%
|
$8,772
$43.56 P/Share
|
|
Jan 31
2023
|
Jeffrey Gene Lee |
BUY
Exercise of conversion of derivative security
|
Direct |
204
+50.0%
|
-
|
|
Jan 31
2022
|
Christopher Accettella |
SELL
Sale (or disposition) back to the issuer
|
Direct |
203
-22.91%
|
$9,135
$45.1 P/Share
|
|
Jan 31
2022
|
Christopher Accettella |
BUY
Exercise of conversion of derivative security
|
Direct |
203
+18.64%
|
-
|
Last 12 Months Summary
| Exercise of conversion of derivative security | 16K shares |
|---|
| Sale (or disposition) back to the issuer | 16K shares |
|---|